$237.15 Million in Sales Expected for Prestige Consumer Healthcare Inc (NYSE:PBH) This Quarter

Wall Street analysts forecast that Prestige Consumer Healthcare Inc (NYSE:PBH) will post $237.15 million in sales for the current fiscal quarter, Zacks reports. Four analysts have made estimates for Prestige Consumer Healthcare’s earnings. The lowest sales estimate is $236.00 million and the highest is $238.60 million. Prestige Consumer Healthcare reported sales of $239.36 million during the same quarter last year, which would suggest a negative year-over-year growth rate of 0.9%. The company is expected to report its next quarterly earnings report before the market opens on Thursday, October 31st.

According to Zacks, analysts expect that Prestige Consumer Healthcare will report full year sales of $953.73 million for the current year, with estimates ranging from $951.00 million to $955.10 million. For the next fiscal year, analysts forecast that the business will post sales of $963.18 million, with estimates ranging from $962.40 million to $963.50 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that cover Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 1st. The company reported $0.65 earnings per share for the quarter, beating analysts’ consensus estimates of $0.64 by $0.01. The company had revenue of $232.15 million for the quarter, compared to the consensus estimate of $231.52 million. Prestige Consumer Healthcare had a positive return on equity of 12.45% and a negative net margin of 3.81%. The firm’s quarterly revenue was down 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.68 EPS.

Several equities research analysts recently issued reports on PBH shares. TheStreet raised Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research note on Tuesday, July 23rd. ValuEngine upgraded Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a report on Friday, July 26th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $61.07.

Shares of PBH traded up $0.55 on Friday, reaching $36.36. 13,843 shares of the company’s stock traded hands, compared to its average volume of 432,056. The company has a current ratio of 2.16, a quick ratio of 1.26 and a debt-to-equity ratio of 1.63. The stock has a market cap of $1.77 billion, a PE ratio of 13.07, a PEG ratio of 1.89 and a beta of 0.89. The stock’s 50 day simple moving average is $33.67 and its two-hundred day simple moving average is $31.42. Prestige Consumer Healthcare has a 52-week low of $26.25 and a 52-week high of $41.76.

Several hedge funds have recently modified their holdings of PBH. Arizona State Retirement System raised its holdings in Prestige Consumer Healthcare by 1.1% in the 2nd quarter. Arizona State Retirement System now owns 37,594 shares of the company’s stock valued at $1,191,000 after acquiring an additional 400 shares in the last quarter. Pitcairn Co. raised its holdings in Prestige Consumer Healthcare by 5.2% in the 2nd quarter. Pitcairn Co. now owns 12,236 shares of the company’s stock valued at $388,000 after acquiring an additional 608 shares in the last quarter. Diversified Trust Co raised its holdings in Prestige Consumer Healthcare by 8.2% in the 2nd quarter. Diversified Trust Co now owns 8,575 shares of the company’s stock valued at $272,000 after acquiring an additional 650 shares in the last quarter. United Services Automobile Association raised its holdings in Prestige Consumer Healthcare by 4.0% in the 2nd quarter. United Services Automobile Association now owns 24,270 shares of the company’s stock valued at $769,000 after acquiring an additional 929 shares in the last quarter. Finally, Flinton Capital Management LLC raised its holdings in Prestige Consumer Healthcare by 20.6% in the 2nd quarter. Flinton Capital Management LLC now owns 8,816 shares of the company’s stock valued at $279,000 after acquiring an additional 1,504 shares in the last quarter.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

See Also: Penny Stocks, Risk and Reward Factors

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.